Brought to you by WBIW News and Network Indiana
Last updated on Wednesday, December 12, 2007
(WEST LAFAYETTE) - Purdue has begun manufacturing an antibiotic for drug-resistant tuberculosis.
An American lawyer threw a scare into dozens of airline passengers when he defied warnings about his TB to go on a European honeymoon. But he's one of only 10-thousand or so people in the U.S. and Canada to contract that strain of TB -- not enough to make it worth Eli Lilly's while to keep manufacturing the drug that can treat it.
Lilly struck a deal giving Purdue's Chao Center exclusive rights to make and distribute seromycin in the U.S. and Canada.
Lilly has partnered with 13 other organizations to manufacture the drug overseas.
1340 AM WBIW welcomes comments and suggestions by calling 812.277.1340 during normal business hours or by email at firstname.lastname@example.org
© Ad-Venture Media, Inc. All Rights Reserved.
Click here to go back to previous page